Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug.
about
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System DisordersCase Series Using Montelukast in Patients with Memory Loss and Dementia.The G Protein-Coupled Receptor GPR17: Overview and Update.Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis.Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERKDiscovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitroNeuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.T cell costimulation blockade blunts pressure overload-induced heart failure.Hippocampal CysLT1R knockdown or blockade represses LPS-induced depressive behaviors and neuroinflammatory response in mice.Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target.Intertwining extracellular nucleotides and their receptors with Ca2+ in determining adult neural stem cell survival, proliferation and final fate.Vitamin D, reactive oxygen species and calcium signalling in ageing and disease.Regulation of adult neural progenitor cell functions by purinergic signaling.Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous SystemIndomethacin Increases Neurogenesis across Age Groups and Improves Delayed Probe Trial Difference Scores in Middle-Aged Rats.Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified.An Update on P2Y13 Receptor Signalling and Function.PEGylation corannulene enhances response of stress through promoting neurogenesis.Puerarin and Amlodipine Improvement of D-Galactose-Induced Impairments of Behaviour and Neurogenesis in Mouse Dentate Gyrus: Correlation with Glucocorticoid Receptor Expression.[Doping for the brain].Ageing: Restoration project.Epigenome-Wide Association Study of Cognitive Functioning in Middle-Aged Monozygotic Twins.Reactive Neuroblastosis in Huntington's Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain.G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination.The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brainLoss of Trem2 in microglia leads to widespread disruption of cell coexpression networks in mouse brain
P2860
Q28278005-A19889D9-CD4D-4B3D-8A17-AF50F2D1D291Q33645060-115F0C09-DC87-4DE2-849F-8235B81FA08EQ34545058-BCE0FAE1-4FA0-4645-A548-48F54A84137DQ35914881-F1578E8D-5375-47D7-8C24-763127E24191Q36476821-3BE5CB02-4F31-46C5-B86A-2191E294EC8CQ36681733-5393573A-72DC-499A-95E1-D809F951CA76Q37442060-7A54BE1B-96A7-4CC7-8340-947313729A57Q37576743-07257BAB-EFBC-4CAB-BD33-271D2E068906Q37690286-57DF400E-F115-4A12-83D6-408C0CA8036BQ37744756-DD498138-919D-4757-A809-00EF6ECA63C6Q38614708-9BDEBE00-89BB-420A-A4BC-161E34AD2600Q38728679-673EEBD8-342B-4E72-9196-215C9132324BQ38785505-FE10C54A-4E68-4256-B299-7F21A2BA4F48Q38885842-AD21B841-356D-4E75-A58B-D3AA1F2B71C9Q38885846-AFBACB75-FA06-460A-BCB2-4DDD089ED910Q38954776-61ACBFDD-8F16-4296-A5D2-A325DE5E2C54Q39335873-20D368F0-EB51-41F0-A55D-8732C7A6176CQ41457247-A82C2C26-A18F-4C82-AAB2-802210AB9146Q41585770-F3FE047E-27BC-49F8-8546-C4AFA73BF280Q47943130-B561F647-08F1-4E9A-8E7F-FE727ECB5999Q48128315-4A7A6795-DADF-4224-AAE4-073B1DDDE341Q48143800-0F8523AB-A79B-4C71-99BF-E68EAD096E7BQ48171249-50552A28-42BC-491F-BDB2-DE1F106CDFFAQ48866168-803DA2E9-6A59-42AD-AC71-0FEEED6A2777Q49623121-C67C98A5-E0C3-4244-B080-2C8D54C100A1Q51758698-80A770AC-C81E-4E7C-BAA7-B309D076F1ECQ52355330-D3FFB960-35CB-4B8A-BEC5-73FD4D7A3FAFQ56967481-AC676E28-4C13-425B-931A-3F82DA40FC4CQ58778218-5D3186AC-10E7-4B79-B92F-478A437A103F
P2860
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Structural and functional reju ...... n approved anti-asthmatic drug
@nl
Structural and functional reju ...... approved anti-asthmatic drug.
@ast
Structural and functional reju ...... approved anti-asthmatic drug.
@en
type
label
Structural and functional reju ...... n approved anti-asthmatic drug
@nl
Structural and functional reju ...... approved anti-asthmatic drug.
@ast
Structural and functional reju ...... approved anti-asthmatic drug.
@en
prefLabel
Structural and functional reju ...... n approved anti-asthmatic drug
@nl
Structural and functional reju ...... approved anti-asthmatic drug.
@ast
Structural and functional reju ...... approved anti-asthmatic drug.
@en
P2093
P2860
P50
P356
P1476
Structural and functional reju ...... approved anti-asthmatic drug.
@en
P2093
Barbara Klein
Claudia Schmuckermair
D Chichung Lie
Florian B Lagler
Ingmar Blümcke
Iris Schäffner
Julia Marschallinger
Ludwig Aigner
Lukas Grassner
Mansoor Chishty
P2860
P2888
P356
10.1038/NCOMMS9466
P407
P50
P577
2015-10-27T00:00:00Z
P5875
P6179
1011779962